Atria Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.06M | Sell |
|
|||||
|
2025
Q2 | $1.14M | Sell |
|
|||||
|
2025
Q1 | $2.85M | Buy |
|
|||||
|
2024
Q4 | $3.3M | Sell |
|
|||||
|
2024
Q3 | $4.01M | Sell |
|
|||||
|
2024
Q2 | $4.36M | Buy |
|
|||||
|
2024
Q1 | $4.74M | Buy |
|
|||||
|
2023
Q4 | $3.46M | Buy |
|
|||||
|
2023
Q3 | $2.54M | Buy |
|
|||||
|
2023
Q2 | $2.53M | Buy |
|
|||||
|
2023
Q1 | $2.29M | Buy |
|
|||||
|
2022
Q4 | $2.44M | Buy |
|
|||||
|
2022
Q3 | $1.74M | Sell |
|
|||||
|
2022
Q2 | $2.21M | Sell |
|
|||||
|
2022
Q1 | $3.02M | Sell |
|
|||||
|
2021
Q4 | $4.75M | Sell |
|
|||||
|
2021
Q3 | $5.29M | Buy |
|
|||||
|
2021
Q2 | $4.48M | Buy |
|
|||||
|
2021
Q1 | $2.67M | Buy |
|
|||||
|
2020
Q4 | $2.18M | Buy |
|
|||||
|
2020
Q3 | $1.94M | Buy |
|
|||||
|
2020
Q2 | $1.46M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $922K | Buy |
|
|||||
|
2019
Q3 | $515K | Sell |
|
|||||
|
2019
Q2 | $564K | Buy |
|
|||||
|
2019
Q1 | $471K | Sell |
|
|||||
|
2018
Q4 | $631K | Sell |
|
|||||
|
2018
Q3 | $777K | Buy |
|
|||||
|
2018
Q2 | $442K | Buy |
|
|||||
|
2018
Q1 | $397K | Buy |
|
|||||
|
2017
Q4 | $343K | Sell |
|
|||||
|
2017
Q3 | $488K | Buy |
|